Clinical Trials

Search Form

Disease Site Trial Sort descending Trial Description Trial Status Lead Cooperative Group
Symptom Benefit ENGOT-EN16/ NOGGO S22/ Expression XI

IMPROVE - International Survey for Endometrial Cancer patients: perspective and expectation on therapy and quality of life

Recruiting NOGGO
Symptom Benefit ENGOT-OV22/ NOGGO S8 / Expression IV

Ovarian cancer patients’ expectations in respect of maintenance therapy 

Completed NOGGO
Symptom Benefit ENTO-OV40/ NOGGO S13/ Expression VI

Caroline meets HANNA – Holistic Analysis of long-term survivors with ovarian cancer

Recruiting NOGGO
Symptom Benefit/Ovarian SYMPTOM BENEFIT

Does Palliative Chemotherapy Improve Symptoms in Women with Recurrent Ovarian Cancer?

Completed ANZGOG
Translational Research ENGOT-OV47/ NOGGO TR2/ HELP-ER

Prospective Study of HE4 serum Level in Patients with First Platinum Sensitive Ovarian Cancer Relapse

Recruiting NOGGO
Uterine Leiomyosarcoma GOG0277

Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observtion in Treating Patients with High Risk Uterine Leiomyosarcoma Previously removed by Surgery 

Completed GOG-F
Uterine Sarcoma EORTC 62113-55115

A Randomized Double-blind Phase II Study Evaluating the Role of Maintenance Therapy With Cabozantinib in High Grade Undifferentiated Uterine Sarcoma (HGUS) After Stabilization or Response to Doxorubicin +/- Ifosfamide Following Surgery or in Metastatic First Line Treatment

Recruiting EORTC-GCG
Vulvar GOG0279

Radiation Therapy, Gemcitabine Hydrochloride and Cisplatin in Treating Patients with Locally Advanced Squamous Cell Carcinoma of the Vulva

Recruiting GOG-F

Groningen International Study on Sentinel Nodes in Vulvar Cancer-III (GROINSS-VIII)

Recruiting DGOG